Mesquida M - Search Results

1

Human immunocompetent choroid-on-chip: a novel tool for studying ocular effects of biological drugs.

Cipriano M, Schlünder K, Probst C, Linke K, Weiss M, Fischer MJ, Mesch L, Achberger K, Liebau S, Mesquida M, Nicolini V, Schneider A, Giusti AM, Kustermann S, Loskill P. Cipriano M, et al. Among authors: mesquida m. Commun Biol. 2022 Jan 13;5(1):52. doi: 10.1038/s42003-021-02977-3. Commun Biol. 2022. PMID: 35027657 Free PMC article.

2

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro.

Mesquida M, Drawnel F, Lait PJ, Copland DA, Stimpson ML, Llorenç V, Sainz de la Maza M, Adan A, Widmer G, Strassburger P, Fauser S, Dick AD, Lee RWJ, Molins B. Mesquida M, et al. Transl Vis Sci Technol. 2019 Oct 28;8(5):32. doi: 10.1167/tvst.8.5.32. eCollection 2019 Sep. Transl Vis Sci Technol. 2019. PMID: 31667008 Free PMC article.

3

Bioengineering approaches for modelling retinal pathologies of the outer blood-retinal barrier.

Molins B, Mesquida M, Adan A. Molins B, et al. Among authors: mesquida m. Prog Retin Eye Res. 2022 Jul 12:101097. doi: 10.1016/j.preteyeres.2022.101097. Online ahead of print. Prog Retin Eye Res. 2022. PMID: 35840488 Review.

4

Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.

Mesquida M, Molins B, Llorenç V, Sainz de la Maza M, Adán A. Mesquida M, et al. Ophthalmology. 2014 Dec;121(12):2380-6. doi: 10.1016/j.ophtha.2014.06.050. Epub 2014 Sep 6. Ophthalmology. 2014. PMID: 25204610

5

C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function.

Molins B, Pascual A, Méndez, Llorenç V, Zarranz-Ventura J, Mesquida M, Adán A, Martorell J. Molins B, et al. Among authors: mesquida m. Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C244-C253. doi: 10.1152/ajpcell.00057.2016. Epub 2016 Dec 21. Am J Physiol Cell Physiol. 2017. PMID: 28003224 Free article.

6

Bacillus Calmette-Guérin Infection and Cytotoxicity in the Retinal Pigment Epithelium.

Llorenç V, Mesquida M, Molins B, González-Martín J, Sainz de la Maza M, Adán A. Llorenç V, et al. Among authors: mesquida m. Ocul Immunol Inflamm. 2018;26(5):786-792. doi: 10.1080/09273948.2016.1265655. Epub 2016 Dec 23. Ocul Immunol Inflamm. 2018. PMID: 28010156

7

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.

Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Sainz de la Maza M, Adán A. Mesquida M, et al. Retina. 2018 Jul;38(7):1361-1370. doi: 10.1097/IAE.0000000000001690. Retina. 2018. PMID: 28520640

8

Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema.

Matas J, Llorenç V, Fonollosa A, Díaz-Valle D, Esquinas C, de la Maza MTS, Figueras-Roca M, Artaraz J, Berasategui B, Mesquida M, Adán A, Molins B. Matas J, et al. Among authors: mesquida m. Front Immunol. 2020 Sep 25;11:579005. doi: 10.3389/fimmu.2020.579005. eCollection 2020. Front Immunol. 2020. PMID: 33101305 Free PMC article.

9

The role of inflammation in diabetic eye disease.

Mesquida M, Drawnel F, Fauser S. Mesquida M, et al. Semin Immunopathol. 2019 Jul;41(4):427-445. doi: 10.1007/s00281-019-00750-7. Epub 2019 Jun 7. Semin Immunopathol. 2019. PMID: 31175392 Review.

10

Interleukin-6 blockade in ocular inflammatory diseases.

Mesquida M, Leszczynska A, Llorenç V, Adán A. Mesquida M, et al. Clin Exp Immunol. 2014 Jun;176(3):301-9. doi: 10.1111/cei.12295. Clin Exp Immunol. 2014. PMID: 24528300 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters